Clinical study on Tongyan Spray (通咽喷雾剂) for post-stroke dysphagia patients: A randomized controlled trial

Xue-gong Feng; Wen-jie Hao; Zhou Ding; Qiang Sui; Huan Guo; Jian Fu

doi:10.1007/s11655-012-1140-9

Your Location：

Home >

Browse articles >

Clinical study on Tongyan Spray (通咽喷雾剂) for post-stroke dysphagia patients: A randomized controlled trial

OriginalPaper | Updated：2021-08-27

- Clinical study on Tongyan Spray (通咽喷雾剂) for post-stroke dysphagia patients: A randomized controlled trial
- Clinical study on Tongyan Spray (通咽喷雾剂) for post-stroke dysphagia patients: A randomized controlled trial
- 中国结合医学杂志（英文版） 2012年18卷第5期页码：345-349
- Affiliations：
  
  Neurology Department of Beijng Hospital of Traditional Chinese and Western Medicine,Beijing,China
- Author bio：
- Funds：
  
  Supported by the Project of Beijing Traditional Chinese Medicine Scientific Program (No.JJ2007-010)
- DOI：10.1007/s11655-012-1140-9
  中图分类号：
- 纸质出版日期：2012，
  
  网络出版日期：2012-3-16，
Scan for full text
Feng, Xg., Hao, Wj., Ding, Z. et al. Clinical study on Tongyan Spray (通咽喷雾剂) for post-stroke dysphagia patients: A randomized controlled trial., Chin. J. Integr. Med. 18, 345–349 (2012). https://doi.org/10.1007/s11655-012-1140-9

Xue-gong Feng, Wen-jie Hao, Zhou Ding, et al. Clinical study on Tongyan Spray (通咽喷雾剂) for post-stroke dysphagia patients: A randomized controlled trial[J]. Chinese Journal of Integrative Medicine, 2012,18(5):345-349.
Feng, Xg., Hao, Wj., Ding, Z. et al. Clinical study on Tongyan Spray (通咽喷雾剂) for post-stroke dysphagia patients: A randomized controlled trial., Chin. J. Integr. Med. 18, 345–349 (2012). https://doi.org/10.1007/s11655-012-1140-9 DOI：

Xue-gong Feng, Wen-jie Hao, Zhou Ding, et al. Clinical study on Tongyan Spray (通咽喷雾剂) for post-stroke dysphagia patients: A randomized controlled trial[J]. Chinese Journal of Integrative Medicine, 2012,18(5):345-349. DOI： 10.1007/s11655-012-1140-9.

摘要

To observe the effectiveness and safety of Tongyan Spray (通咽喷雾剂) composed of Chinese medicine for post-stroke dysphagia patients. One hundred and twenty-two post-stroke dysphagia patients were randomly assigned to the treatment group (61 cases) and the control group (61 cases). Basic treatment was given to both groups

with Tongyan Spray additionally used in oropharynx for the treatment group

and the placebo used for the control group. After 28-day treatment

the clinical effect and safety were evaluated according to the standard swallowing assessment (SSA) scale. One patient dropped out in each group

and 120 patients reached the final analysis of the study. The total effective rate for the treatment group was 71.7% (43/60)

higher than 46.7% (28/60) in the control group (P<0.05)

and the improvement on SSA scores of the two groups were significantly different after treatment (P<0.05). For grade 1 dysphagia patients (completely depending on nasogastric tube)

the effective rate of the treatment group was 40.9% (9/22)

and 12.5% (2/16) of the control group

without significant difference (P>0.05)

while the improvement of SSA score was significantly different between the two groups after treatment (P<0.05). For grade 2–3 dysphagia patients (oral and nasogastric tube feeding)

the total effective rate of the treatment group was 89.5% (34/38)

higher than 59.1% (26/44) in the control group (P<0.05)

and also the improvement on SSA scores was significantly different between the two groups after treatment (P<0.05). Tongyan Spray was an effective and safe method for post-stroke dysphagia patients.

Abstract

with Tongyan Spray additionally used in oropharynx for the treatment group

and the placebo used for the control group. After 28-day treatment

the clinical effect and safety were evaluated according to the standard swallowing assessment (SSA) scale. One patient dropped out in each group

and 120 patients reached the final analysis of the study. The total effective rate for the treatment group was 71.7% (43/60)

higher than 46.7% (28/60) in the control group (P<0.05)

and the improvement on SSA scores of the two groups were significantly different after treatment (P<0.05). For grade 1 dysphagia patients (completely depending on nasogastric tube)

the effective rate of the treatment group was 40.9% (9/22)

and 12.5% (2/16) of the control group

without significant difference (P>0.05)

while the improvement of SSA score was significantly different between the two groups after treatment (P<0.05). For grade 2–3 dysphagia patients (oral and nasogastric tube feeding)

the total effective rate of the treatment group was 89.5% (34/38)

higher than 59.1% (26/44) in the control group (P<0.05)

and also the improvement on SSA scores was significantly different between the two groups after treatment (P<0.05). Tongyan Spray was an effective and safe method for post-stroke dysphagia patients.

关键词

post-strokedysphagiaTongyan Spray

Keywords

post-strokedysphagiaTongyan Spray

references

Han TR, Paik NJ, Park JW. Quantifying swallowing function after stroke: a functional dysphagia scale based on videofluoroscopic studies. Arch Phys Med Rehabilit 2001;82:677–682.

Smithard DG, O’Neill PA, Parks C, Morris J. Complications and outcome after acute stroke. Does dysphagia matter? Stroke 1996;27:1200–1204.

The 4th National Cerebrovascular Disease Conference. The key points for diagnosis of different cerebrovascular diseases.Chin J Neurol (Chin) 1996;29:379.

Smithard DG, O’Neill PA, Park C, England R, Renwick DS, Wyatt R, et al. Can bedside assessment reliably exclude aspiration following acute stroke? Age Ageing 1998;27:99–106.

Liu ZS, Liu BY, Zhang W, Sun SC, Wang DW, Liu J. Clincal Study on acupuncture treatment for moderate and severe deglutition disorders at the chronic stage of apoplexy. Chin Acupunct Moxib (Chin) 2002;22:291–294.

Wang YJ, Lu DH, Cui LY, Li WH, ed. Progress of modern neurology, 3rd ed. Beijing: Science and Technology Document Publishing House; 2004:247.

The Encephalopathic Emergency Cooperation Group of the State Administration of Traditional Chinese Medicine. The diagnosis and curative effect assessment standard for stroke. J Beijing Univ Tradit Chin Med (Chin) 1996;19:55–56.

Davalos A, Ricart W, Gonzalez HF, Soler S, Marrugat J, Molin A, et al. Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996,27:1028–1032.

Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence,diagnosis, and pulmonary complications. Stroke 2005;36:2756–2763.

Feng XG, Cai YF, Deng YH. 30 cases of stroke with pseudobulbar palsy by Tongyan Drops. Chin J Inform Tradit Chin Med (Chin) 2003;10:61–62.

Logemann JA. Criteria for studies of treatment for oralpharyngeal dysphagia. Dysphagia 1987;1:193–199.

Xiang DQ, Peng SF, Luo MZ. Care and treatment of patients with cerebrovascular disease dysphagia. West Chin Med J (Chin) 2001;16:379–380.

Zheng SY. Comparative study of Zhongjing with ginger and modern pharmacology and the application. Strait Pharm J (Chin) 2002;14:94–95.

Zhu SS, ed. New formulations of drugs. Beijing: Chemical Industry Press; 2003:251.

Westergren A. Detection of eating difficulties after stroke: a systematic review. Int Nurs Rev 2006;53:143–149.

Dodds WJ, Logemann JA, Stewart ET. Radiologic assessment of abnormal oraland pharyngeal phases of swallowing. AJR Am J Roentgenol 1990;154:965–974.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Therapeutic effect of acupuncture combining standard swallowing training for post-stroke dysphagia: A prospective cohort study

Acupuncture Treatment for Post-Stroke Dysphagia: An Update Meta-Analysis of Randomized Controlled Trials